search
Back to results

Psychostimulant Abuse - Novel Treatment Approaches - 1

Primary Purpose

Cocaine-Related Disorders

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Gonadorelin
Sponsored by
National Institute on Drug Abuse (NIDA)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring cocaine dependence

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)MaleDoes not accept healthy volunteers

Please contact site for information.

Sites / Locations

  • McLean Hospital, Dept. of Psychiatry

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Mclean Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00000325
Brief Title
Psychostimulant Abuse - Novel Treatment Approaches - 1
Official Title
Psychostimulant Abuse - Novel Treatment Approaches
Study Type
Interventional

2. Study Status

Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2001 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Mclean Hospital

4. Oversight

5. Study Description

Brief Summary
To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
cocaine dependence

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Enrollment
0 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Gonadorelin

10. Eligibility

Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jack Mendelson, M.D.
Organizational Affiliation
Mclean Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
McLean Hospital, Dept. of Psychiatry
City
Belmont
State/Province
Massachusetts
ZIP/Postal Code
2178
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Psychostimulant Abuse - Novel Treatment Approaches - 1

We'll reach out to this number within 24 hrs